IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 50 di 195
Titolo Data di pubblicazione Autore(i) File
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading 1-gen-2016 Guerra, E.; Cimadamore, A.; Simeone, P.; Vacca, G.; Lattanzio, R.; Botti, G.; Gatta, V.; D'Aurora, M.; Simionati, B.; Piantelli, M.; Alberti, S.
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 1-gen-2017 Cimadamore, Alessia; Scarpelli, Marina; Piva, Francesco; Massari, Francesco; Gasparrini, Silvia; Doria, Andrea; Cheng, Liang; Lopez beltran, Antonio; Montironi, Rodolfo
Whole slide imaging of large format histology in prostate pathology: Potential for information fusion 1-gen-2017 Montironi, Rodolfo; Cimadamore, Alessia; Massari, Francesco; Montironi, Maria Alessandra; Lopez-Beltran, Antonio; Cheng, Liang; Montorsi, Francesco; Scarpelli, Marina
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 1-gen-2017 Montironi, R.; Gasparrini, S.; Cimadamore, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Moch, H.; Montorsi, F.; Scarpelli, M.
Variants of Bladder Cancer: The Pathologist's Point of View 1-gen-2017 Lopez-Beltran, A.; Cheng, L.; Raspollini, M. R.; Canas-Marques, R.; Scarpelli, M.; Cimadamore, A.; Gasparrini, S.; Montironi, R.
Epigenetic modifications and modulators in prostate cancer 1-gen-2017 Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Doria, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression 1-gen-2017 Cimadamore, Alessia; Gasparrini, Silvia; Mazzucchelli, Roberta; Doria, Andrea; Cheng, Liang; Lopez-Beltran, Antonio; Santoni, Matteo; Scarpelli, Marina; Montironi, Rodolfo
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 1-gen-2017 Montironi, R.; Gasparrini, S.; Cimadamore, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Briganti, A.; Scarpelli, M.
Pathology and molecular updates in tumors of the prostate: towards a personalized approach 1-gen-2017 Gasparrini, Silvia; Cimadamore, Alessia; Mazzucchelli, Roberta; Scarpelli, Marina; Massari, F; Raspollini, Mr; Galosi, Andrea Benedetto; Lopez Beltran, A; Cheng, L; Montironi, Rodolfo
Immunotherapy in genitourinary cancers: Where are we going? 1-gen-2017 Bianconi, M.; Faloppi, L.; Lopez-Beltran, A.; Cheng, L.; Cimadamore, A.; Gasparrini, S.; Massari, F.; Scarpelli, M.; Montironi, R.
Are liver nested stromal epithelial tumors always low aggressive? 1-gen-2017 Meletani, T; Cantini, L; Lanese, A; Nicolini, D; Cimadamore, A; Agostini, A; Ricci, Giulia; Antognoli, S; Mandolesi, A; Cortelazzo, GUIDO MARIA; Alaggio, R; Giuseppetti, Gm; Scarpelli, M; Vivarelli, M; Berardi, R.
Re: Isabel Rauscher, Charlotte Düwel, Bernhard Haller, et al. Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy. Eur Urol 2018;73:656–61: Clinical Significance of Prostate-specific Membrane Antigen Immunohistochemistry and Role of the Uropathologists 1-gen-2018 Cimadamore, A.; Scarpelli, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R.
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer 1-gen-2018 Di Nunno, V.; Gatto, L.; Santoni, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Scarpelli, M.; Montironi, R.; Massari, F.
Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy 1-gen-2018 Cimadamore, A.; Scarpelli, M.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Emerging Molecular Technologies in Genitourinary Tumors 1-gen-2018 Giunchi, Francesca; Cimadamore, Alessia; Fiorentino, Michelangelo
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 1-gen-2018 Cimadamore, A.; Gasparrini, S.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Giunchi, F.; Fiorentino, M.; Scarpelli, M.; Montironi, R.
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications 1-gen-2018 Santoni, M.; Massari, F.; Di Nunno, V.; Conti, A.; Cimadamore, A.; Scarpelli, M.; Montironi, R.; Cheng, L.; Battelli, N.; Lopez-Beltran, A.
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 1-gen-2018 Massari, F.; Santoni, M.; di Nunno, V.; Cheng, L.; Lopez-Beltran, A.; Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Battelli, N.; Montironi, R.
Prostate cancer grading in 2018: Limitations, implementations, cribriform morphology, and biological markers 1-gen-2018 Montironi, R.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.
The identification of immunological biomarkers in kidney cancers 1-gen-2018 Lopez-Beltran, A.; Henriques, V.; Cimadamore, A.; Santoni, M.; Cheng, L.; Gevaert, T.; Blanca, A.; Massari, F.; Scarpelli, M.; Montironi, R.
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 1-gen-2018 Di Nunno, Vincenzo; Cimadamore, Alessia; Santoni, Matteo; Scarpelli, Marina; Fiorentino, Michelangelo; Ciccarese, Chiara; Iacovelli, Roberto; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Montironi, Rodolfo
Quick steps toward precision medicine in renal cell carcinoma 1-gen-2018 Massari, F.; Santoni, M.; Di Nunno, V.; Cimadamore, A.; Battelli, N.; Scarpelli, M.; Cheng, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
Emerging prognostic biomarkers in testicular germ cell tumors: Looking beyond established practice 1-gen-2018 Chovanec, M.; Albany, C.; Mego, M.; Montironi, R.; Cimadamore, A.; Cheng, L.
Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560–9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step? 1-gen-2018 Di Nunno, V.; Santoni, M.; Cimadamore, A.; Battelli, N.; Massari, F.
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors 1-gen-2018 Santoni, Matteo; Piva, Francesco; Conti, Alessandro; Santoni, Angela; Cimadamore, Alessia; Scarpelli, Marina; Battelli, Nicola; Montironi, Rodolfo
Exploring small extracellular vesicles for precision medicine in prostate cancer 1-gen-2018 Giulietti, Matteo; Santoni, Matteo; Cimadamore, Alessia; Carrozza, Francesco; Piva, Francesco; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Battelli, Nicola; Montironi, Rodolfo
New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen 1-gen-2018 Cimadamore, A.; Cheng, M.; Santoni, M.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Galosi, A. B.; Scarpelli, M.; Montironi, R.
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma 1-gen-2018 Montironi, R; Cimadamore, A; Gasparrini, S; Mazzucchelli, R; Santoni, M; Massari, F; Cheng, L; Lopez-Beltran, A; Scarpelli, M.
Tivozanib for the treatment of renal cell carcinoma 1-gen-2018 Santoni, Matteo; Massari, Francesco; Piva, Francesco; Carrozza, Francesco; Di Nunno, Vincenzo; Cimadamore, Alessia; Martignetti, Angelo; Montironi, Rodolfo; Battelli, Nicola
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 1-gen-2019 Fiordoliva, Ilaria; Marcantognini, Giulia; Rinaldi, Silvia; Cimadamore, Alessia; Montironi, Rodolfo; Berardi, Rossana
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 1-gen-2019 Mollica, V.; Di Nunno, V.; Gatto, L.; Santoni, M.; Scarpelli, M.; Cimadamore, A.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R.; Massari, F.
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples 1-gen-2019 Volavsek, M.; Henriques, V.; Blanca, A.; Montironi, R.; Cheng, L.; Raspollini, M. R.; Cimadamore, A.; Vau, N.; Pierconti, F.; Lopez-Beltran, A.
Microbiome and cancers, with focus on genitourinary tumors 1-gen-2019 Cimadamore, A.; Santoni, M.; Massari, F.; Gasparrini, S.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Scarpelli, M.
Circulating tumor cells in renal cell carcinoma: Recent findings and future challenges 1-gen-2019 Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Scarpelli, M.; Galosi, A. B.; Bracarda, S.; Montironi, R.
Prostate Cancer Grading: Are We Heading Towards Grade Grouping Version 2? 1-gen-2019 Montironi, R.; Cheng, L.; Cimadamore, A.; Lopez-Beltran, A.
OUTCOMES OF DIFFERENT PATTERN OF SEMINAL VESICLE INVASION IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY 1-gen-2019 Montesi, L; Palagonia, E; Leone, L; Capretti, C; Cimadamore, A; Dell'Atti, L; Galosi, Ab; Montironi, R
Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice 1-gen-2019 Massari, F.; Nunno, V. D.; Mollica, V.; Montironi, R.; Cheng, L.; Cimadamore, A.; Blanca, A.; Lopez-Beltran, A.
Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer 1-gen-2019 Blanca, A.; Sanchez-Gonzalez, A.; Requena, M. J.; Carrasco-Valiente, J.; Gomez-Gomez, E.; Cheng, L.; Cimadamore, A.; Montironi, R.; Lopez-Beltran, A.
Emerging molecular technologies in renal cell carcinoma: Liquid biopsy 1-gen-2019 Cimadamore, A.; Gasparrini, S.; Massari, F.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.
Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667–75: How Does Circulating DNA Reach the Blood Stream? 1-gen-2019 Montironi, R.; Cheng, L.; Scarpelli, M.; Cimadamore, A.; Montorsi, F.; Lopez-Beltran, A.
Prostate cancer pathology: What has changed in the last 5 years 1-gen-2019 Cimadamore, Alessia; Scarpelli, Marina; Raspollini, Maria Rosaria; Doria, Andrea; Galosi, Andrea Benedetto; Massari, Francesco; Di Nunno, Vincenzo; Cheng, Liang; Lopez-Beltran, Antonio; Montironi, Rodolfo
Inguinal bladder hernia with lipomatosis of the bladder wall: A potential clinical pitfall for cancer 1-gen-2019 Cimadamore, Alessia; Palagonia, Erika; Piccinni, Paola; Misericordia, Marco; Galosi, Andrea Benedetto; Montironi, Rodolfo
Genitourinary tumors: Update on molecular biomarkers for diagnosis, prognosis and prediction of response to therapy 1-gen-2019 Cimadamore, A.; Scarpelli, M.; Santoni, M.; Massari, F.; Tartari, F.; Cerqueti, R.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
The Prostatic Utricle and Endometrioid Prostate Cancer: Similarities, Differences and Challenges 1-gen-2019 Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M
Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer 1-gen-2019 Mollica, Veronica; Di Nunno, Vincenzo; Cimadamore, Alessia; Lopez-Beltran, Antonio; Cheng, Liang; Santoni, Matteo; Scarpelli, Marina; Montironi, Rodolfo; Massari, Francesco
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 1-gen-2019 Santoni, Matteo; Heng, Daniel Yc; Aurilio, Gaetano; Iozzelli, Andrea; Servi, Lucilla; Fabiani, Andrea; Giannini, Massimo; Mazzucchelli, Roberta; Cimadamore, Alessia; Scarpelli, Marina; Zaghloul, Mohamed S; Battelli, Nicola; Montironi, Rodolfo
Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype 1-gen-2019 Rebola, J.; Aguiar, P.; Blanca, A.; Montironi, R.; Cimadamore, A.; Cheng, L.; Henriques, V.; Lobato-Faria, P.; Lopez-Beltran, A.
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 1-gen-2019 Santoni, M.; Conti, A.; Massari, F.; Di Nunno, V.; Faloppi, L.; Galizia, E.; Morbiducci, J.; Piva, F.; Buti, S.; Iacovelli, R.; Ferretti, B.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Montironi, R.
The role of obesity in renal cell carcinoma patients: Clinical-pathological implications 1-gen-2019 Aurilio, G.; Piva, F.; Santoni, M.; Cimadamore, A.; Sorgentoni, G.; Lopez-Beltran, A.; Cheng, L.; Battelli, N.; Nole, F.; Montironi, R.
Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers 1-gen-2019 Santoni, M.; Cimadamore, A.; Massari, F.; Piva, F.; Aurilio, G.; Martignetti, A.; Scarpelli, M.; Di Nunno, V.; Gatto, L.; Battelli, N.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Mostrati risultati da 1 a 50 di 195
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile